The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...

Novo Nordisk announced it had signed a deal with Vivtex, a biotech co-founded by MIT professor Robert Langer, to develop oral ...

The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to explore how biotechnology and artificial ...

Reporting from AGBT in Orlando, Julianna LeMieux checks in with Kevin Davies to review key announcements from the meeting.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

New month, new movies and more to watch on Prime Video that we have to tell you all about. Love is in the air as we snuggle closer and closer to Valentine’s Day, which means Prime Video is laying out ...

Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months. M&A activity in the biotech industry has been forecasted to accelerate in ...

If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...

The deal builds on a 2022 collaboration between Arcellx and Kite, a Gilead company, and eliminates profit-sharing and milestone structures, consolidating economics under Gilead as it deepens its ...

Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the public markets. The California biotech, which is working on preclinical stem ...

Add Yahoo as a preferred source to see more of our stories on Google. The lab is a first-of-its-kind in the region - built to mirror what students can expect working in biotechnology. According to Bio ...

Michelle Ross, StemPoint Capital CIO, joins 'Power Lunch' to discuss why biotech stocks are taking a breather and where the best market opportunities are. Got a confidential news tip? We want to hear ...